Cross-linking as Treatment in Infectious Keratitis

NCT04383431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2023-01-18

No results posted yet for this study

Summary

To compare between SCXL and ACXL for treatment of infectious keratitis

Conditions

  • Infectious Keratitis

Interventions

PROCEDURE

PACK-CXL

Standard epithelium-off CXL, 12 minutes soaking time with riboflavin, 8 minutes UVA corneal irradiation pulsed mode.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Mohammed Iqbal, MD. PhP · 00201068559840

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-02
Primary Completion
2023-01-01
Completion
2023-01-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383431 on ClinicalTrials.gov